ORIGINAL ARTICLE

Antibacterial activity of fresh pomegranate juice against clinical strains of Staphylococcus epidermidis

Gabriel Betanzos-Cabrera1*, Perla Y. Montes-Rubio1, Héctor E. Fabela-Illescas1, Helen Belefant-Miller2 and Juan C. Cancino-Diaz3

1Área Académica de Nutrición, Instituto de Ciencias de la Salud, Universidad Autónoma del Estado de Hidalgo, Hidalgo, Mexico; 2Dale Bumpers National Rice Research Center, Stuttgart, AR, USA; 3Departamento de Microbiología, Escuela Nacional de Ciencias Biológicas del Instituto Politécnico Nacional, Mexico City, Mexico

Abstract

Background: Polyphenols have received a great deal of attention due to their biological functions. Pomegranate (Punica granatum L.) is a polyphenol-rich fruit. In the past decade, studies testing the antimicrobial activity of pomegranates almost exclusively used solvent extracts instead of fresh pomegranate juice (FPJ). The use of FPJ instead of solvent extracts would reduce toxicity issues while increasing patient acceptance. We established a model to test FPJ as a natural antimicrobial agent.

Objective: To evaluate the antimicrobial activity of FPJ on clinical isolates of multidrug-resistant Staphylococcus epidermidis strains.

Design: Sixty strains of S. epidermidis isolated from ocular infections were grown in the presence of FPJ, and minimum inhibitory concentration (MIC) was determined by broth and agar dilution methods.

Results: FPJ at 20% had a MIC equal to 100% (MIC100%) on all 60 strains tested. This inhibition of FPJ was confirmed by the growth kinetics of a multidrug-resistant strain exposed to different concentrations of FPJ. Additionally, the antimicrobial activity of FPJ was compared against commercial beverages containing pomegranate: Ocean Spray® had a MIC100% at 20%, followed by Del Valle® with a MIC15% at 20% concentration only. The beverages Jumex® and Sonrisa® did not have any antimicrobial activity. FPJ had the highest polyphenol content and antioxidant capacity.

Conclusions: Overall, FPJ had antimicrobial activity, which might be attributed to its high polyphenol content and antioxidant capacity.

Keywords: pomegranate juice; Staphylococcus epidermidis; antimicrobial activity; antioxidant capacity; ocular infections

Citation: Food & Nutrition Research 2015, 59: 27620 - http://dx.doi.org/10.3402/fnr.v59.27620

Copyright: © 2015 Gabriel Betanzos-Cabrera et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for any purpose, even commercially, provided the original work is properly cited and states its license.

Received: 16 February 2015; Revised: 24 March 2015; Accepted: 27 March 2015; Published: 20 May 2015

Competing interests and funding: The authors declare they have no conflict of interest regarding the publication of this paper.

*Correspondence to: Gabriel Betanzos-Cabrera, Universidad Autónoma del Estado de Hidalgo, Abasolo 600, 42000 Pachuca de Soto, México, Email: gbetanzo@uaeh.edu.mx

 

Pomegranate (Punica granatum L.) is the fruit of a tree belonging to the family Punicaceae. It is native from Iran to the Himalayas in northern India and has been cultivated and naturalized over the entire Mediterranean region since ancient times (1, 2). The ripe fruit contains many arils separated by a white, membranous pericarp (1). Studies show that pomegranate juice (PJ) has potent antioxidant activity (ability to scavenge free radicals), significantly higher than more commonly consumed fruit juices such as grape, cranberry, grapefruit, and orange (35). This activity has been attributed to antioxidant polyphenols, including ellagitannins (hydrolyzable tannins) and anthocyanins (condensed tannins) (6). Punicalagins are the major ellagitannins in the whole fruit and can be hydrolyzed to ellagic acid and other smaller polyphenols in vivo (1, 7).

Pomegranate has been used in traditional medicine for the treatment of dysentery, diarrhea, helminthiasis, and respiratory pathologies (811). Currently there is considerable interest toward evaluating plant sources for alternative treatments against multidrug-resistant pathogenic bacteria. The antimicrobial activity of pomegranate has been documented with different extracts (8, 1215) and the potential therapeutic applications of the antimicrobial properties of pomegranate components have been investigated in human and murine models (1, 4, 1621). However, FPJ antimicrobial activity has not been explored in spite of its high content of antioxidants.

There is a great interest in identifying antimicrobial compounds against Staphylococcus epidermidis because it, along with S. aureus, are public health problems due to their high incidence in hospitals. They also have a high capacity for resistance to antibiotics and other compounds, such as benzalkonium chloride and ethidium bromide, including inhibition of host immune responses (22). Their resistance to antibiotics is a result of their strong ability to produce biofilm. A biofilm is a multi-aggregate of microorganisms embedded in an exopolysaccharide with a high capacity for adherence to biotic and abiotic surfaces, protecting the bacteria from antibiotics and the immune system. The impact of infections by S. epidermidis has caused losses of $2 billion annually in the United States (23). Different commercial pomegranate-based beverages claim to have high antioxidant potency based only on their polyphenol content as determined by in vitro antioxidant assays (24). However, this does not necessarily indicate their biological activity and related health benefits. We compared FPJ activity with commercial pomegranate-based beverages for their ability to kill S. epidermidis and determined their total antioxidant activities. Antimicrobial activity has not been tested on pathogenic strains of S. epidermidis, so the aim of this work was to determine the antimicrobial activity of FPJ on clinical strains of multidrug-resistant S. epidermidis.

Methods

Fresh pomegranate juice

Pomegranates (P. granatum L.) were collected in Valle de Mezquital, Hidalgo, Mexico, in September 2012 and identified by Manuel González Ledesma, MSc, Universidad Autónoma de Hidalgo. A voucher specimen (U10) is deposited at the herbarium of the Department of Botany, Universidad Autónoma del Estado de Hidalgo, Mexico.

The fruit was handpicked, washed, and stored at 4°C. Fresh aril juice was used to ensure that the results would be valid for juice as consumed by humans. The fruit was peeled, and the arils were crushed and then squeezed with a household juicing appliance. The FPJ was sterilized by filtration with a 0.22 µm membrane (Millipore Corporation, Billerica, MA, USA) prior to use.

Commercial pomegranate beverages

The four commercial beverages used for this study were those distributed nationally in Mexico and were purchased from a supermarket. All beverages were kept at storage conditions as specified on their labels prior to analysis. The beverages tested were 1) Del Valle® ANTIOX (Batch 0471121631 13:42:57 CAD 16AGO11, Mexico D.F.); 2) Jumex® SuperFrutas (Batch 2L B10J133 12:43 CAD 13OCT11, Mexico D.F); 3) Sonrisa® Good 4 You (Batch 20510 CAD 24ENE12 Mexico D.F.); and 4) Ocean Spray® Cranberry & Pomegranate (Batch CT8410209PP02 CAD 17MAY11 Lakeville-Middleboro, MA, USA).

Bacterial strains, culture media, and growth conditions

Sixty strains of S. epidermidis isolated from human ocular infections (25, 26) were obtained from the Instituto de Oftalmología Conde de Valenciana, Mexico City. Their resistance to antibiotic and biocides are shown in Table 1. Half of the strains were resistant to multiple drugs and other compounds, such as ethidium bromide and benzalkonium chloride, and some of them were also biofilm producers. S. epidermidis strains were grown in Mueller Hinton broth (Becton Dickinson, Sparks, MD, USA) at 37°C for 24 h.


Table 1.  Staphylococcus epidermidis strains with antibiotic and biocide resistance that were included in the study
Strains Antibiotic resistance Ocular infection Biofilm production MIC to EtBr (μg/mL) MIC to BeCh (μg/mL)
51 Oxa, Tob, Cef, Cet, Pol, Sul, Amp Conjunctivitis Negative ND ND
60 Oxa, Ofl, Tob, Cef, Cet, Pol, Sul, Amp Conjunctivitis Positive ND ND
61 Oxa, Nor, Ofl, Tob, Cef, Pol, Sul, Amp Conjunctivitis Positive ND ND
63 Ofl, Tob, Nor, Gen, Cef, Cet, Tet, Pol, Sul Endophthalmitis Positive 50 8
71 Oxa, Tob, Cet, Tet, Pol, Amp Conjunctivitis Negative 100 4
93 Oxa, Cip, Ofl, Tob, Neo, Cef, Cet, Sul Endophthalmitis Positive ND ND
95 Oxa, Tob, Cef, Tet, Pol, Sul, Amp Endophthalmitis Positive 5 1
96 Tob, Cef, Pol, Sul, Amp Endophthalmitis Positive >300 8
98 Oxa, Tob, Gen, Cef, Cet, Sul Endophthalmitis Negative 100 8
106 Oxa, Ofl, Tob, Gen, Cef, Cet, Sul Conjunctivitis Positive ND ND
144 Oxa, Ofl, Tob, Neo, Gen, Cef, Cet, Tet, Sul, Amp Corneal ulcer Positive 50 4
146 Oxa, Cip, Tob, Cef, Sul Corneal ulcer Positive ND ND
155 Pol, Sul Conjunctivitis Positive 5 1
199 Oxa, Nor, Ofl, Cef, Cet, Pol, Sul Corneal ulcer Negative ND ND
214 Oxa, Cip, Ofl, Tob, Neo, Gen, Nor, Cet, Sul Endophthalmitis Positive 100 4
215 Oxa, Tob, Neo, Gen, Pol, Sul, Amp Conjunctivitis Negative 100 8
1655 Cef, Cet, Pol Conjunctivitis Positive 10 2
1660 Tob, Cef, Cet, Pol, Amp Conjunctivitis Negative 10 2
1682 Oxa, Tob, Cep, Van, Sul Conjunctivitis Negative 100 8
1700 Gen, Tet Conjunctivitis Positive 10 2
1774 Oxa, Cef, Cet, Tet, Sul, Amp Endophthalmitis Negative 50 8
1784–2 Tob, Neo, Gen, Cet, Sul Conjunctivitis Positive ND ND
1819 Neo, Cef, Cet, Amp Endophthalmitis Negative 100 4
1843 Tob, Neo Conjunctivitis Positive >300 8
1864 Cef, Amp Corneal ulcer Positive ND ND
1980 Tob, Tet, Sul, Amp Endophthalmitis Negative ND ND
2009 Cef, Amp Endophthalmitis Negative 100 8
2022 Oxa, Tob, Gen, Cef, Cet, Tet, Sul Corneal ulcer Negative 100 4
2038 Oxa, Ofl, Tob, Gen, Cef, Cet, Tet Endophthalmitis Positive 100 8
2050 Oxa, Cip, Ofl, Tob, Gen, Nor, Cef, Cet, Tet, Sul, Amp Conjunctivitis Negative 100 8
Note: The table only shows the 30 strains resistant to antibiotics of the 60 total studied.
Amp, ampicillin; Cef, ceftazidime; Cep, cephalothin; Cet, ceftriaxone; Cip, ciprofloxacin; EtBr, ethidium bromide; Gen, gentamicin; Neo, neomycin; Nor, norfloxacin; Ofl, ofloxacin; Oxa, oxacillin; Pol, polymyxin B; Sul, sulfisoxazole; Tet, tetracycline; Tob, tobramycin; Van, vancomycin; minimum inhibitory concentration (MIC)≥50 μg/mL is considered resistant. BeCh, benzalkonium chloride; MIC≥4 μg/mL is considered resistant. ND, not determined.

Determination of MICs

The procedure to determine the MICs was performed according to the Clinical and Laboratory Standards Institute criteria (27). Briefly, for the broth dilution method, Mueller Hinton broth inoculated with ~104 CFU ml−1 (adjusted to a turbidity of 0.5 McFarland) of each strain was supplemented aseptically with serial dilutions of FPJ or beverages to obtain concentrations from 0 to 20% (v/v), then the tubes were incubated at 37°C. MICs were determined visually at 24 and 48 h. For the agar dilution method, Petri dishes were prepared with Mueller Hinton agar plus the desired concentration of FPJ or commercial beverage. After hardening, the agar media were aseptically inoculated with 20 µL (~104 CFU ml−1) of the tested bacterium. The lowest concentration of PJ or beverage capable of inhibiting visible growth after 48 h was recorded as the MIC. Each experiment was performed in triplicate.

Growth curve of S. epidermidis

From an overnight culture, 20 µL of strain 144 (a bacterium selected for its biofilm production and multidrug resistance) were inoculated into Erlenmeyer flasks containing 50 ml of Mueller Hinton media supplemented with FPJ at the same concentrations used for the MIC. The cultures were incubated on a shaker at 37°C. The developing turbidity was measured using light absorption at 600 nm at time 0 and at 1 h intervals for 5 h. Uninoculated culture medium was used as blank.

Total phenolic content

Total polyphenols were determined spectrophotometrically using the Folin–Ciocalteu method described by Singleton and Rossi (28). Total phenolics of FPJ and beverages were calculated and reported as gallic acid equivalents.

Antioxidant assay – Trolox equivalent antioxidant capacity

Trolox equivalent antioxidant capacity (TEAC) was estimated as 2′,2′-azinobis(3-ethylbenzothiazline-6-sulfonic acid) diammonium salt (ABTS) radical scavenging activity according to the method of Re et al. (29). Briefly, ABTS (Sigma Aldrich, St. Louis, MO, USA) was dissolved in water to make a 7 mM concentration. ABTS radical cation (ABTS•+) was produced by reacting ABTS stock solution with 2.45 mM potassium persulfate (final concentration) and allowing the mixture to stand in the dark at room temperature for 12–16 h. The antioxidant standard was 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox). A standard calibration curve was constructed for Trolox in ethanol (Sigma Aldrich) at 0, 50, 100, 150 and 200 mg/L. One hundred microliters of diluted samples were mixed with 900 µl of ABTS•+, and 200 µl of the mix were placed into 96-well plates, and absorbance at 734 nm was read after 5 min in a micro plate reader (Biotek®, Winooski, VT, USA). Samples were assayed in six replicates. TEAC values were calculated from the Trolox standard curve and expressed as Trolox equivalents (mg/L).

Antioxidant assay free radical scavenging capacity

The free radical scavenging capacity was analyzed by 1,1-diphenyl-2-picrylhydrazyl (DPPH) assay according to the method of Morales and Jiménez-Pérez (30). Briefly, 100 µl of FPJ or beverages were mixed with 900 µl of a methanolic solution of 0.25 mM DPPH (Sigma Aldrich). The mixture was shaken and incubated at room temperature for 30 min, 200 µl were placed into 96-well plates, and the change in optical density at 520 nm was continuously monitored using a reader (Biotek®). Trolox was used as standard. Samples were assayed in six replicates. Percent inhibition was calculated from control using the following equation:

Statistical analysis

A one-way ANOVA with a Tukey test was used to analyze the results of bacterial growth kinetics, total phenolics, and antioxidant assays. The results were expressed as mean±SD. Differences were considered significant at p<0.05.

Results

Antimicrobial activity of FPJ in clinical strains of S. epidermidis

Sixty clinical strains of S. epidermidis isolated from ocular infections were tested to observe the antimicrobial activity of FPJ. FPJ at 20% completely inhibited the growth of all 60 strains (Fig. 1a and b). Ampicillin was used as the control in measuring resistance to antimicrobial activity. Figure 1c shows various strains that were resistant to this ampicillin but were sensitive to FPJ at 20%.

Fig 1

Fig. 1.   Antimicrobial activity of fresh pomegranate juice (FPJ). The following results are representative of all strains studied. Growth of 16 S. epidermidis strains (in duplicate), (a) unsupplemented, (b) supplemented with 20% FPJ, or (c) supplemented with 100 µg/mL of ampicillin. Note that six strains were resistant to this antibiotic.

Table 1 shows the phenotypes of 30 strains of S. epidermidis having resistance to multiple drugs, ethidium bromide, or benzalkonium chloride. In spite of their multiresistance, all these strains were sensitive to FPJ at 20%. The other 30 strains that were sensitive to antibiotics were also sensitive to FPJ and also were not biofilm producers (data not shown).

Antimicrobial activity of commercial pomegranate-based beverages

Figure 2 shows the antimicrobial activity of FPJ and various pomegranate beverages at 20% on S. epidermidis strains. FPJ and pomegranate beverages at less than 20% concentrations had no inhibitory effect. Both FPJ and Ocean Spray® at 20% inhibited 100% of bacteria (MIC100%=20%), while Del Valle® at 20% only inhibited 15% of the strains. Neither Jumex® nor Sonrisa® showed inhibitory effects at any concentration used (MIC0%=20%). The presence of a beverage, with the exception of Jumex® and Sonrisa®, appeared to reduce the colony size (FPJ=Ocean Spray®>Del Valle®>Jumex®=Sonrisa®) (Fig. 3). It should be noted that adding FPJ or beverages to the culture medium did not alter the pH value (data not shown).

Fig 2

Fig. 2.   Percentage of growth inhibition of S. epidermidis by FPJ and beverages containing pomegranate. The results are for broth as well as agar. The concentration of each juice was 20%. Each assay was made in triplicate.

Fig 3

Fig. 3.   Comparison of antimicrobial activity between FPJ and commercial pomegranate-based beverages. An example of the effect of beverage concentration on strains 144 and 2050 (A and B, respectively) in duplicate. Control – Mueller Hinton media without FPJ; Amp – Mueller Hinton media containing 100 µg/mL of ampicillin; FPJ – fresh pomegranate juice; OSY – Ocean Spray®; DVE – Del Valle®; JUX – Jumex®; and SOA – Sonrisa®.

Effect of FPJ on growth of S. epidermidis 144

In order to observe the effect of FPJ on the growth of the multiresistant and high biofilm producer strain 144, a bacterial growth curve was performed (Fig. 4). Even at low concentrations, the FPJ had an inhibitory effect on S. epidermidis growth while 20% FPJ completely inhibited growth for 5 h.

Fig 4

Fig. 4.   Effect of the concentration of FPJ on microbial growth of S epidermidis strain 144. Mueller Hinton broth was used for the growth curve. Control – growth without FPJ. Different letters represent significant differences (p<0.05) between the control and different concentrations (-◼- Control, -▲- 10%, -● -15%, -◆-20%) of FPJ according to a one-way ANOVA with a Tukey test.

Total polyphenol contents and antioxidant activity assays of FPJ and commercial pomegranate beverages

The total polyphenol content of FPJ and pomegranate-based beverages occurred in the following order: FPJ>Ocean Spray®>Del Valle®>Jumex®=Sonrisa® (Fig. 5). FPJ also had the highest antioxidant capacity in the two assays employed (Fig. 6a and b). When the measurements for polyphenols and antioxidants were combined into a single index of antioxidant activity (Fig. 6c), the rank order was the same as for the antimicrobial activity (Fig. 2).

Fig 5

Fig. 5.   Total polyphenolics as gallic acid equivalents (GAE). Total polyphenol content was determined by the Folin-Ciocalteu method for all beverages. Fresh PJ – fresh pomegranate juice. An asterisk (*) indicates a significant difference (p<0.05) between FPJ and that beverage, according to a one-way ANOVA with a Tukey test.

Fig 6

Fig. 6.   Antioxidant capacity of fresh pomegranate juice and pomegranate-based beverages. The antioxidant capacity was assayed by Trolox equivalent antioxidant capacity (TEAC) and 1-diphenyl-2-picrylhydrazyl (panels a and b, respectively). PJ – fresh pomegranate juice. Antioxidant index score=[(sample score/best score)×100] (panel c), average for all six tests for each beverage for the antioxidant potency composite index. An asterisk (*) indicates a significant difference (p<0.05) between FPJ and that beverage, according to a one-way ANOVA with a Tukey test.

Discussion

S. epidermidis and S. aureus have acquired clinical importance because of their high prevalence in nosocomials and are found frequently in medical devices (31). Their infection capacity has been attributed to the production of biofilms and to their resistance to multiple antibiotics.

In this work, an MIC of 20% was observed for FPJ, which does not appear to indicate a strong antimicrobial effect. However, it should be taken into account that undiluted FPJ contains over 80% water. Therefore, a higher volume is necessary in order to produce a strong antimicrobial effect, unless concentrate or extracts are obtained. This work cannot be directly compared to others that used organic solvent extracts, because FPJ is only derived from the arils, whereas many organic extracts use other parts of the fruit, that is, the peel, whole fruit, or rind. Concentration and volume differences would also make comparisons difficult. Several extracts and concentrates have been demonstrated to have antimicrobial activity against a variety of bacteria, for example: methanolic extracts of the fruit rind (32); chloroform, ethanol, and water extracts of the pomegranate plant (33); pomegranate fruit liquid extracts (ethanolic and butanolic) (10); methanolic extract of pomegranate peels (12); acetone, methanol, ethanol, and water extracts from pomegranate (34); and ethanolic extract of pomegranate peel (9). However, we suggest that FPJ would be a historically safe, convenient, and highly palatable method with similar results to those of extracts.

Several compounds responsible for the antimicrobial action of each pomegranate beverage, depending on their abundance. One example is tannins (abundant in pomegranate), which are considered to be toxic to microorganisms (35). Their hydrophilic part interacts with the polar region of the membrane, whereas the hydrophobic part is immersed in the non-polar inner region of the bacterial membrane, which can cause instability of the membrane, thus affecting the transport of substrates into the cell (36). Likewise, Naz et al. (37) suggest a phenolic toxicity through reactions with sulfhydryl groups or through more non-specific interactions with proteins leading to loss of function.

On the other hand, phenols may also render substrates unavailable to microorganisms or interfere with bacterial protein secretions (24). Additionally, high-performance liquid chromatography analyses have shown that the major phenolic compounds in pomegranate are gallic acid and ellagic acid, in addition to punicalagin as a major ellagitannin. Thus, it is reasonable to consider that these compounds may be responsible for the antimicrobial activity, as suggested by Ahn et al. (38). However, it might be possible that other unidentified compounds contribute to this activity.

It is well known that industrialized food loses some of its properties compared to unprocessed food. Pomegranate-based industrialized beverages were tested to find if they keep or lose antibacterial activity relative to fresh juice. Although Ocean Spray® beverage had the same MIC as FPJ, Del Valle® had only 15% antibacterial activity, whereas Jumex® and Sonrisa® beverages did not have any (Fig. 2). Ocean Spray had the same antibacterial activity compared to FPJ. However, it should be noted that this beverage’s label states that it contains not only pomegranate concentrate, but also a variety of other fruit concentrates, including grape, apple, plum, and cranberry, which may have contributed to the antibacterial activity. Commercial products commonly claim to have antioxidant potency from a high content of polyphenols; however, this claim is usually based only on a limited number of antioxidant tests. When we applied two tests of antioxidant potency, TEAC and DPPH, and calculated an overall antioxidant potency composite index, we saw slight differences between individual polyphenol measurements; however, when combined into an antioxidant index, the rankings matched the percent inhibition. The results of antioxidant capacity were consistent with Seeram et al. (24), who used four methods, including the two tested in this work, and demonstrated that the compounds have different abilities as antioxidants and therefore calculating an antioxidant potency composite index is recommended in order to get a reliable measurement.

Clinical S. epidermidis strains are a good test organism for evaluating antibacterial activity because of the high genomic variation in this microorganism, even to being considered a microorganism with an open pangenome (23). In this work, FPJ exhibited antibacterial activity against 60 strains of S. epidermidis. A future challenge will be to test the antimicrobial activity of FPJ against other microorganisms of medical importance including fungi, viruses, and bacteria isolated from foods; we expect to find the same effect with FPJ because previous reports have demonstrated such activity using extracts (10, 12, 3234).

In human and murine models, PJ has been shown to exert several potential health benefits, including antihypertensive (1618, 39, 40), antiatherosclerotic (16, 20), and anti-inflammatory effects (21, 41, 42). Extracts or commercial beverages may contain a wide range of synthetic antimicrobial compounds, such as sodium benzoate, sorbate, and synthetic antioxidants, that are used as food preservatives but can be harmful (43), so FPJ may be more beneficial.

Conclusions

The antimicrobial activity of FPJ on pathogenic bacteria described here could provide an alternative natural antibacterial treatment, although further studies should be conducted on a wide variety of bacteria and direct relationships established between antimicrobial activity and polyphenols. Identification of the antimicrobial agents in PJ could also yield valuable information.

Acknowledgements

Financial support for this work was provided by CONACYT SALUD-2010-01-142035 PDC Problemas Nacionales PDCPN2013–01. Juan Carlos Cancino-Díaz is a fellow at COFAA-IPN, EDI-IPN, and SNI-CONACYT. We also thank Fernando Chimal for his assistance in editing this work.

References

  1. Jurenka JS. Therapeutic applications of pomegranate (Punica granatum L.): a review. Altern Med Rev 2008; 13: 128–44. PubMed Abstract
  2. Meerts IATM, Verspeek-Rip CM, Buskens CAF, Keizer HG, Bassaganya-Riera J, Jouni ZE, et al. Toxicological evaluation of pomegranate seed oil. Food Chem Toxicol 2009; 47: 1085–92. PubMed Abstract | Publisher Full Text
  3. Azadzoi KM, Schulman RN, Aviram M, Siroky MB. Oxidative stress in arteriogenic erectile dysfunction: prophylactic role of antioxidants. J Urol 2005; 174: 386–93. PubMed Abstract | Publisher Full Text
  4. Basu A, Penugonda K. Pomegranate juice: a heart-healthy fruit juice. Nutr Rev 2009; 67: 49–56. PubMed Abstract | Publisher Full Text
  5. Guo C, Wei J, Yang J, Xu J, Pang W, Jiang Y. Pomegranate juice is potentially better than apple juice in improving antioxidant function in elderly subjects. Nutr Res 2008; 28: 72–7. PubMed Abstract | Publisher Full Text
  6. Cowan MM. Plant products as antimicrobial agents. Clin Microbiol Rev 1999; 12: 564–82. PubMed Abstract | PubMed Central Full Text
  7. Lansky EP, Newman RA. Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer. J Ethnopharmacol 2007; 109: 177–206. PubMed Abstract | Publisher Full Text
  8. Braga LC, Shupp JW, Cummings C, Jett M, Takahashi JA, Carmo LS, et al. Pomegranate extract inhibits Staphylococcus aureus growth and subsequent enterotoxin production. J Ethnopharmacol 2005; 96: 335–9. PubMed Abstract | Publisher Full Text
  9. Choi JG, Kang OH, Lee YS, Chae HS, Oh YC, Brice OO, et al. In vitro and in vivo antibacterial activity of Punica granatum peel ethanol extract against salmonella. Evid Based Complement Alternat Med 2011; 2011: 690518. PubMed Abstract | PubMed Central Full Text
  10. Reddy MK, Gupta SK, Jacob MR, Khan SI, Ferreira D. Antioxidant, antimalarial and antimicrobial activities of tannin-rich fractions, ellagitannins and phenolic acids from Punica granatum L. Planta Med 2007; 73: 461–7. PubMed Abstract | Publisher Full Text
  11. Sánchez-Lamar A, Fonseca G, Fuentes JL, Cozzi R, Cundari E, Fiore M, et al. Assessment of the genotoxic risk of Punica granatum L. (Punicaceae) whole fruit extracts. J Ethnopharmacol 2008; 115: 416–22. Publisher Full Text
  12. Al-Zoreky NS. Antimicrobial activity of pomegranate (Punica granatum L.) fruit peels. Int J Food Microbiol 2009; 134: 244–8. PubMed Abstract | Publisher Full Text
  13. Gould SWJ, Fielder MD, Kelly AF, Naughton DP. Anti-microbial activities of pomegranate rind extracts: enhancement by cupric sulphate against clinical isolates of S. aureus, MRSA and PVL positive CA-MSSA. BMC Complement Altern Med 2009; 9: 23. PubMed Abstract | PubMed Central Full Text | Publisher Full Text
  14. Machado TB, Pinto AV, Pinto MCFR, Leal ICR, Silva MG, Amaral ACF, et al. In vitro activity of Brazilian medicinal plants, naturally occurring naphthoquinones and their analogues, against methicillin-resistant Staphylococcus aureus. Int J Antimicrob Agents 2003; 21: 279–84. PubMed Abstract | Publisher Full Text
  15. Opara LU, Al-Ani MR, Al-Shuaibi YS. Physico-chemical properties, vitamin C content, and antimicrobial properties of pomegranate fruit (Punica granatum L.). Food Bioprocess Technol 2008; 2: 315–21. Publisher Full Text
  16. Aviram M, Volkova N, Coleman R, Dreher M, Reddy MK, Ferreira D, et al. Pomegranate phenolics from the peels, arils, and flowers are antiatherogenic: studies in vivo in atherosclerotic apolipoprotein e-deficient (E 0) mice and in vitro in cultured macrophages and lipoproteins. J Agric Food Chem 2008; 56: 1148–57. PubMed Abstract | Publisher Full Text
  17. Betanzos-Cabrera G, Guerrero-Solano JA, Martínez-Pérez MM, Calderón-Ramos ZG, Belefant-Miller H, Cancino-Diaz JC. Pomegranate juice increases levels of paraoxonase1 (PON1) expression and enzymatic activity in streptozotocin-induced diabetic mice fed with a high-fat diet. Food Res Int 2011; 44: 1381–5. Publisher Full Text
  18. Sumner MD, Elliott-Eller M, Weidner G, Daubenmier JJ, Chew MH, Marlin R, et al. Effects of pomegranate juice consumption on myocardial perfusion in patients with coronary heart disease. Am J Cardiol 2005; 96: 810–14. PubMed Abstract | Publisher Full Text
  19. Rock W, Rosenblat M, Miller-Lotan R, Levy AP, Elias M, Aviram M. Consumption of Wonderful variety pomegranate juice and extract by diabetic patients increases paraoxonase 1 association with high-density lipoprotein and stimulates its catalytic activities. J Agric Food Chem 2008; 56: 8704–13. PubMed Abstract | Publisher Full Text
  20. Rosenblat M, Hayek T, Aviram M. Anti-oxidative effects of pomegranate juice (PJ) consumption by diabetic patients on serum and on macrophages. Atherosclerosis 2006; 187: 363–71. PubMed Abstract | Publisher Full Text
  21. Shukla M, Gupta K, Rasheed Z, Khan KA, Haqqi TM. Consumption of hydrolyzable tannins-rich pomegranate extract suppresses inflammation and joint damage in rheumatoid arthritis. Nutrition 2008; 24: 733–43. PubMed Abstract | PubMed Central Full Text | Publisher Full Text
  22. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284: 1318–22. PubMed Abstract | Publisher Full Text
  23. Rogers KL, Fey PD, Rupp ME. Coagulase-negative staphylococcal infections. Infect Dis Clin North Am 2009; 23: 73–98. PubMed Abstract | Publisher Full Text
  24. Seeram NP, Aviram M, Zhang Y, Henning SM, Feng L, Dreher M, et al. Comparison of antioxidant potency of commonly consumed polyphenol-rich beverages in the United States. J Agric Food Chem 2008; 56: 1415–22. PubMed Abstract | Publisher Full Text
  25. Betanzos-Cabrera G, Juárez-Verdayes MA, González-González G, Cancino-Díaz ME, Cancino-Díaz JC. Gatifloxacin, moxifloxacin, and balofloxacin resistance due to mutations in the gyrA and parC genes of Staphylococcus epidermidis strains isolated from patients with endophthalmitis, corneal ulcers and conjunctivitis. Ophthalmic Res 2009; 42: 43–8. PubMed Abstract | Publisher Full Text
  26. Juárez-Verdayes MA, Reyes-López MA, Cancino-Díaz ME, Muñoz-Salas S, Rodríguez-Martínez S, de la Serna FJZ-D, et al. Isolation, vancomycin resistance and biofilm production of Staphylococcus epidermidis from patients with conjunctivitis, corneal ulcers, and endophthalmitis. Rev Latinoam Microbiol 2006; 48: 238–46.
  27. Clinical and Laboratory Standards Institute 2008. Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement. CLSI document M100–18. Wayne, PA: National Committee for Clinical Laboratory Standars.
  28. Singleton VL, Rossi JA. Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagents. Am J Enol Vitic 1965; 16: 144–58.
  29. Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med 1999; 26: 1231–7. PubMed Abstract | Publisher Full Text
  30. Morales FJ, Jiménez-Pérez S. Free radical scavenging capacity of Maillard reaction products as related to colour and fluorescence. Food Chem 2001; 72: 119–25. Publisher Full Text
  31. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32: 470–85. Publisher Full Text
  32. Prashanth D, Asha MK, Amit A. Antibacterial activity of Punica granatum. Fitoterapia 2001; 72: 171–3. PubMed Abstract | Publisher Full Text
  33. Voravuthikunchai SP, Sririrak T, Limsuwan S, Supawita T, Lida T, Honda T. Inhibitory effects of active compounds from Punica granatum pericarp on Verocytotoxin production by Enterohemorrhagic Escherichia coli O157: H7. J Health Sci 2005; 51: 590–6. Publisher Full Text
  34. Mathabe MC, Nikolova RV, Lall N, Nyazema NZ. Antibacterial activities of medicinal plants used for the treatment of diarrhoea in Limpopo Province, South Africa. J Ethnopharmacol 2006; 105: 286–93. PubMed Abstract | Publisher Full Text
  35. Viuda-Martos M, Fernández-López J, Pérez-Álvarez JA. Pomegranate and its many functional components as related to human health: a review. Compr Rev Food Sci Food Saf 2010; 9: 635–54. Publisher Full Text
  36. Cristani M, D’Arrigo M, Mandalari G, Castelli F, Sarpietro MG, Micieli D, et al. Interaction of four monoterpenes contained in essential oils with model membranes: implications for their antibacterial activity. J Agric Food Chem 2007; 55: 6300–8. PubMed Abstract | Publisher Full Text
  37. Naz S, Siddiqi R, Ahmad S, Rasool SA, Sayeed SA. Antibacterial activity directed isolation of compounds from Punica granatum. J Food Sci 2007; 72: M341–5. PubMed Abstract | Publisher Full Text
  38. Ahn YJ, Lee CO, Kweon JH, Ahn JW, Park JH. Growth-inhibitory effects of Galla Rhois-derived tannins on intestinal bacteria. J Appl Microbiol 1998; 84: 439–43. PubMed Abstract | Publisher Full Text
  39. Aviram M, Dornfeld L, Kaplan M, Coleman R, Gaitini D, Nitecki S, et al. Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans. Drugs Exp Clin Res 2002; 28: 49–62. PubMed Abstract
  40. Aviram M, Dornfeld L, Rosenblat M, Volkova N, Kaplan M, Coleman R, et al. Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr 2000; 71: 1062–76. PubMed Abstract
  41. De Nigris F, Balestrieri ML, Williams-Ignarro S, D’Armiento FP, Fiorito C, Ignarro LJ, et al. The influence of pomegranate fruit extract in comparison to regular pomegranate juice and seed oil on nitric oxide and arterial function in obese Zucker rats. Nitric Oxide 2007; 17: 50–4. PubMed Abstract | Publisher Full Text
  42. Ignarro LJ, Byrns RE, Sumi D, de Nigris F, Napoli C. Pomegranate juice protects nitric oxide against oxidative destruction and enhances the biological actions of nitric oxide. Nitric Oxide 2006; 15: 93–102. PubMed Abstract | Publisher Full Text
  43. Gupta D, Gupta RK. Bioprotective properties of Dragon’s blood resin: in vitro evaluation of antioxidant activity and antimicrobial activity. BMC Complement Altern Med 2011; 11: 13. PubMed Abstract | PubMed Central Full Text | Publisher Full Text